A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors
Clinical trial NCT06248515 · RECRUITING
Trial details
- NCT number
- NCT06248515
- Sponsor
- Georgetown University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-25
- Primary completion
- 2026-04-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.